NCT02701543View on ClinicalTrials.gov

Compare I Pilot Study for the Treatment of Subjects With Symptomatic Femoropopliteal Artery Disease

NACompletedINTERVENTIONAL
Enrollment

414

Participants

Timeline

Start Date

October 31, 2015

Primary Completion Date

October 31, 2018

Study Completion Date

December 31, 2023

Conditions
Peripheral Artery Disease
Interventions
DEVICE

Ranger Drug Eluting Balloon

Percutaneous transluminal angioplasty (PTA), in which a balloon is advanced and inflated in the obstructed artery for several seconds to minutes, has become the standard endovascular treatment for peripheral arteries

DEVICE

In Pact Drug Eluting Balloon

Percutaneous transluminal angioplasty (PTA), in which a balloon is advanced and inflated in the obstructed artery for several seconds to minutes, has become the standard endovascular treatment for peripheral arteries

Trial Locations (1)

04103

University Clinic Leipzig, Leipzig

All Listed Sponsors
lead

University of Leipzig

OTHER

NCT02701543 - Compare I Pilot Study for the Treatment of Subjects With Symptomatic Femoropopliteal Artery Disease | Biotech Hunter | Biotech Hunter